There is great geographical variation in the distribution of hepatocellular carcinoma (HCC),
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …

Abstract The Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma
proposed by the Japan Society of Hepatology was updated in June 2014 at a consensus …

Background: Hepatocellular carcinoma (HCC) is the fifth most common type of cancer and
the third leading cause of cancer-related death worldwide. HCC is most common in Asia, but …

Aim To evaluate the diagnostic per-lesion performance of a simulated gadoxetate disodium-
enhanced abbreviated MRI (AMRI) in cirrhotic and chronic hepatitis B (CHB) patients for …

As opposed to most solid cancers, hepatocellular carcinoma (HCC) does not necessarily
require histological confirmation. Noninvasive diagnosis is possible and relies on imaging …

Surveillance and diagnostic algorithms for hepatocellular carcinoma (HCC) have already
been described in guidelines published by the American Association for the Study of Liver …

Magnetic resonance imaging (MRI) using gadolinium ethoxybenzyl diethylenetriamine
pentaacetic acid (Gd-EOB-DPTA), or gadoxetic acid for short, is a hepatocyte-specific …

MRI is widely used in clinical practice for detecting liver diseases. Since the introduction of
gadoxetic acid, MRI has become the most effective modality for the detection and …

OBJECTIVE. The purpose of this study is to evaluate the outcomes of hypovascular
hypointense nodules in the hepatobiliary phase of gadoxetic acid–enhanced MRI and the …

Hepatocellular carcinoma (HCC) develops via multistep hepatocarcinogenesis, during
which hypovascular/early HCC precedes the typical hypervascular HCC. The hypovascular …